MLPAstats: An R GUI package for the integrated analysis of copy number alterations using MLPA data by Cáceres, Alejandro et al.
SOFTWARE Open Access
MLPAstats:A nR GUI package for the
integrated analysis of copy number alterations
using MLPA data
Alejandro Cáceres
1,2*, Lluís Armengol
3, Sergi Villatoro
4 and Juan R González
1,2,5*
Abstract
Background: Multiplex-Dependent Probe Amplification (MLPA) is a cost-effective experimental method for
candidate gene studies, aimed at the identification of copy number alterations. The analysis of such genetic
variants, from electropherogram peak intensities, involves two main stages. First, peak normalization for each probe
is required to remove the contribution of probe size to peak intensity. Second, the statistical significance of peak
alteration between case and control samples is estimated. A number of methods have been proposed in each step
with varying levels of complexity and precision. However, there is no single framework from which the results of
each method and possible combinations at each step can be assessed.
Results: We present MLPAstats,a nR package designed to integrate the methods for exploring different
analysis scenarios in a reliable way. A GUI has been developed to allow researchers to find their optimal analysis
strategy.
Conclusions: MLPAstats is an analysis tool that promotes the use of cost-effective MLPA suitable for candidate
gene studies. Its R implementation allows future methods to be easily incorporated, while its GUI will facilitate its
use by non-expert analysts. A vignette describing a set-by-step tutorial is also available with the package.
Background
Recent research shows that copy number variations (CNV)
are an important form of inter-individual genetic differ-
ence in the human population. Currently, a popular
approach to identifying novel mechanisms of genetic pre-
disposition to disease is to search for recurrent differences
in the copy number of certain genes between control and
affected populations (the case-control design).
CNV-based studies consist of variant detection, fol-
lowed by testing for association with the phenotypes of
interest. Association testing requires appropriate estima-
tion of copy number status for each genetic probe and
for each sample in the population. Here, we deal with
the detection of CNVs and refer the reader to other
sources for a discussion of association testing, which
may take uncertainty in CNV calling in to account
(CNVassoc package submitted for publication).
The detection of CNVs have been made possible by
recent advancements in experimental technology and
data analysis. In the context of genome-wide studies, a
large amount of genetic regions are scanned with plat-
forms such as aCGH, Illumina or Affymetrix. Complex
segmentation algorithms are required for the identifica-
tion of relevant genetic sequences. As a consequence,
the benefit of testing large number of markers is limited
by the power to accurately detect copy number events.
Studies with targeted genes can be performed with
more precise experimental techniques, such as Multiplex
Ligation-dependent Probe Amplification (MLPA), Quan-
titative Multiplex PCR of Short Fluorescent (QMPSF) or
Multiplex Amplifiable Probe Hybridization (MAPH).
Particularly, MLPA, a semi-qualitative technique, is able
to determine gains or losses in the copy number of the
targeted genomic regions [1]. Some of its most attractive
features are its easy implementation and low cost. In a
case-control design, the method can analyze up to 50
different genomic sequences.
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based, produces an electropherogram of peak intensi-
ties for each probe and subject. The hight of a given
peak depends not only on the number of copies of the
targeted region but also on its probe size. Therefore,
the copy number alteration of the gene between case
and control samples can be measured from the varia-
tion of the peak intensity, accounting for probe size.
Early analyses of MLPA data did not considered
within-subject variability of the probes. In the case of
having replicates, this variability can be assessed and
incorporated in the stages of the analysis as shown by
Gonzalez et al. [2]. This decreases type I error while
increasing statistical power.
Few methods have been developed to detect CNVs
from MLPA data, some of which are offered in Coffa-
lyser,a nExcel package recommended by the manu-
facturer. Although researchers are encouraged to use
Coffalyser for its usability, the software requires a
Microsoft Office license to operate and, more impor-
tantly, it does not incorporate recent developments on
the analysis of MLPA data, such as analysis with repli-
cates [2]. In a previous study, Gerdes and colleagues [3]
implemented a fixed work-flow for the interassay eva-
luation analysis of MLPA kits. More recently, van Eijk et
al. [4] developed MLPAinter, a tool for the visualiza-
tion and the quality control of MLPA data. The tool is
particularly useful for dealing with high number of sam-
ple sizes and identifying stable reference probes. How-
ever, as a stand alone unit, it does not allow the
incorporation of normalization and estimation of dosage
ratios by third parties, and its current implementation
includes a threshold method that does not perform sta-
tistical inferences on the CNV status of the probes.
In this article, we present MLPAstats, a free package
written on R with a GUI that includes both common and
more state-of-the art methodologies. MLPAstats fea-
tures analyses with and without replicates, covering a
wide range of data acquisitions and experimental designs.
Given the variety of possible strategies, the software
allows researchers to explore the optimal analysis for
their data. This includes not only the methods but also
the selection of reference probes and replicate samples.
We first describe the implementation of the software.
Then, we illustrate the package using samples with and
without replicates http://www.creal.cat/jrgonzalez/soft-
ware.htm. We use the GUI in the first case and the com-
mand line in the second sample. And finally, we compare
MLPAstat and Coffalyser on a third data set.
Implementation
The two main steps of an MLPA analysis are the normali-
zation and the inference of copy number alterations. Nor-
malization by probe size is a data pre-processing step that
takes into account the systematic non-biological variation
between samples. Variation c a na r i s ef r o mt h es i z ea n d
nature of the probe, differences in experimental conditions
in each sample, and PCR efficiency. These factors need to
be considered before an assessment of the differences in
copy number between groups can be performed.
The two most common methods of normalization are
based on average (sum) of peak intensities and regres-
sion models. An estimate of the normalization factor is
computed and applied to the original data set. In the
case of no replicates, individual normalization factors
are commonly taken as the total sum of peak intensities
for each subject. If replicates for the subject have been
collected, then the normalization coefficients can be
computed form the peak average across replicates.
Given that the peak intensity decreases with probe size,
the normalization factor can be modeled as a function of
it. A straightforward model is to consider a linear depen-
dence between probe peaks and sizes. Typically, reference
probes are chosen to guide the normalization.
Normalized peak intensities are then used to assess dif-
ferences in copy number between case and control sam-
ples. A simple approach is to examine whether the ratio
between case and control intensities falls outside predefine
thresholds. Ratios lower than 0.7 are considered losses and
ratios over 1.33 are gains in copy number [5,6].
A more suitable approach is Regression-Enhanced
MLPA (REX-MLPA) where the regression between case
and control probes is computed with given confidence
intervals. Outliers of the confidence region are identified
as case probes with altered copy number. Starting with a
regression on reference probes, the method iteratively
includes test probes that are within the confidence inter-
vals, to re-estimate the regression. A final model is fitted
with all the probes within the interval. The probes outside
the confidence limits are considerer significantly altered in
copy number between case and control samples.
If replicates are available, for each subject in the sam-
ple, then the within-subject variation of reference probes
can be used in a mixed model that includes an overall
mean and group effect. In such model, a probe with
altered copy number in the case group has an estimate
that falls outside the confidence interval. The interval is
obtained from the mean of the differences between con-
trol samples, and the estimate of the error variance.
Results
MLPAstats is written in R and can be freely down-
loaded from http://www.cran.r-project.org. For guidance
on how to install and launch the software, see the user’s
manual (additional file 1), also a vignette distributed
with the package. The manual demonstrates a reprodu-
cible step-by-step analysis of experimental data pre-
sented by [2].
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launched from the R command line:
> gui.mlpa()
Figure 1 shows MLPAstats main window. The user can
interactively load and set up the analysis session. This pro-
cess is carried out by creating an Ms.Rdata file in which
data and analysis results are saved at any stage, to be recov-
ered in future sessions. Various analyses strategies can be
explored and saved, so the results are easily reproduced.
Alternatively, the main functions of the software can be
called from the R command line, when data has been con-
veniently loaded and set-up on the R global environment.
In the following sections, we first illustrate the use of
the GUI with a data set that has no replicates, and then
we show how to call the main functions from the com-
mand line, using a sample data set with replicates. Note,
however, that both data sets can be analyzed either way.
Normalization
The normalization procedures implemented in MLPA-
stats include different aspects of the relationship
between peak intensity and probe size. In some occa-
sions, a set of reference probes are sampled to guide the
normalization. Normalization options are:
1. sum peaks controls: Only reference probes are
used for the normalization. All peak intensities are
divided by the sum of reference probe peaks. This
procedure corrects a global factor between the con-
trol and case groups.
2. sum peaks all:I ft h ep r o f i l e so fall probe peaks
across groups seem equivalent up to a factor, then
normalization can be performed by dividing the
peaks by the sum of all probes [1].
3. slope correction: Larger probe sizes have lower
peak intensity. Removal of this effect is done with a
linear regression between the size and the probe
intensity. The regression is preformed on the refer-
ence probes.
4. non linear: If replicates are available, an estima-
tion of the within-subject error can be taken into
account. An exponential decay is further considered
to remove the inverse relationship between probe
size and peak intensity.
To demonstrate the normalization procedure on data
without replicates, a BRCA s a m p l ed a t ac a nb el o a d e d
from the File menu under load demo. The data is from a
breast cancer study (P002 BRCA1) provided by NGRL-
Manchester. It consists on a collection of 34 probes for
10 case and 5 control samples. Nine of the probes are
used as reference probes for the normalization step.
Loading the data will create the Ms.Rdata file on the
present working directory and will update the current
s t a t u so ft h ed a t at ob en o r m a l i z e d .S i n c et h i sd a t ah a s
no replicates it can only be normalized with slope correc-
tion or sum peaks options, found under the Normalize
main menu. The result of the normalization is displayed
in Figure 2 and obtained by selecting from the main win-
dow: Results®plot®normalization®mean controls.
Figure 1 MLPAstats main GUI window. Figure 2 Normalize reults for BRCA data.
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sets up the data for the assessment of differences in
copy number alterations.
Copy Number Alteration
Assessing statistical significance of the peak differences
between case and control samples is the main objective
of MLPAstats. From these inferences, probes are cata-
logued as having a relative gain (1), loss (-1) or no
change (0) in their copy number status between
samples.
Three analyses are implemented in MLPAstats:
1. threshold: A direct comparison between case and
control samples is performed. Ratios between refer-
ence and test peaks that are found outside prede-
fined thresholds are considered as altered. Default
threshold values are 0.7 for deletions and 1.33 for
gains. Different thresholds can be considered.
2. REX-MLPA: Regression enhanced MLPA is based on
an iterative regression between case and control sam-
ples. Starting with control probes the regression defines
Figure 3 Analysis Results using REX-MLPA.
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have no change in copy number. Such probes are used
to re-estimate the thresholds. Test probes that are
finally outside the confidence intervals are classified as
having either a gain or a loss in copy number.
3. mixel-model: The error in the peak intensities for
the control probes can be computed if subject repli-
cates are available. The comprehensive model that
takes into account between probe, probe-test (main
effect), and random variability can substantially
increase the precision of CNV calling [2].
After normalization, MLPAstats computes the copy
number status (-1,0,1) for each case probe relative to
the control probes. For the previously normalized BRCA
data, which has no replicates, only the threshold and the
REX-MLPA method can be used. Under the Analysis
menu the inference methods are listed and followed by
a window where relevant parameters are specified. The
results of a REX-MLPA are shown in Figure 3. The plot
shows the scattered plot of normalized intensities for
case against control samples.
MLPAstatsfrom the command line
Here we illustrate the call of the main functions, for
normalization and copy number alteration inference,
from the command line. We use a data set with repli-
cates, MLPAvalidation, presented in [2]. The data
Figure 4 Analysis Results with replicates using mixed-model option. Markers are shown on the horizontal line and subjects on the vertical
line. Markers with red (green) had a significant loss (gain) in copy number between case and test samples.
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demo under the File menu.
In the command line the data is loaded and set up
with the instructions
> data(MLPAvalidation)
> mlpa.dat<-setupMLPA(controls, cases,
size, reference.probes)
T h ed a t ai ncontrols, cases, sizes and
reference.probes, obtained from MLPAvalida-
tion, has the required format for setupMLPA.N o r -
malization is then performed by calling the function
mlpaNorm
> mlpa.norm<-mlpaNorm(mlpa.dat, meth-
od="sums.peaks.controls”)
mlpa.norm can be plotted or taken forward into the
analysis. The function mlpa, with the appropriate analy-
sis option (mixel-model) for data with replicates
>ans<-mlpa(mlpa.norm, method="mixed-
model”)
>ans
gives the copy number alterations for each probe. An
example of a result display is shown in Figure 4. Equal
results are obtained following the corresponding steps in
the GUI.
comparison between MLPAstats and Coffalyser
We performed a comparison between these two soft-
wares using the sample data distributed with Coffaly-
serhttp://old.mlpa.com/coffalyser/. This is a 17 DMD
samples (13 good sample runs and 2 control runs) and
reference “MLPA mix P034 MLPA probemix lot 1105,
0505, 1004”.W ep e r f o r m e dt h ea n a l y s i sf o l l o w i n gt h e
instructions manual. We filtered and analyzed with the
option “Control Probe Analysis”.T h e n ,f r o mt h e“info”,
“reference runs” and “sample runs” of the Excel sheets,
we collected all the information needed to run MLPA-
stats. For that analysis, we normalized with “sum
peaks control” and estimated dosage ratios with “REX-
MLPA”. We chose that analysis strategy so it would be
s i m i l a rt ot h eo n ew eu s e df o rCoffalyser.T a b l e1
shows the results of both analyses.
We observed that MLPAstats found all the copy
number variants reported by Coffalyser,a n da l s o
detected two more variants in the first and third sample.
Therefore, while both analyses are comparable to each
other, we found that the MLPAstats implementation
has an increased power. Although it should be noted
that MLPAstats reports the ambiguous status on the
third sample as a loss.
We believe that a main advantage of MLPAstats
is, however, its ability to treat multiple replicas of the
samples, for which Coffalyser h a sn oo p t i o n s .I n
addition, a clear division between normalization and
estimation of dosage rations allows for easy
optimization of the analysis strategy. Finally, on the
user’s side, the GUI and its vignette are easier to fol-
low, and the code is publicly open to incorporate
future developments.
Conclusions
Given the accessibility of MLPA experiments, it is desirable
that its data analysis is also usable. The interface of MLPA-
stats has been designed to combine and compare differ-
ent analyses that can be stored and retrieved at any stage.
Effort has also been put into establishing an easy interac-
tion with the user; in particular, into setting up the analysis
and displaying results. The GUI should encourage the wide
use of MLPAstats,r e g a r d l e s so fp r e v i o u sk n o w l e d g ei nR.
The user’s manual, distributed with the package,
further illustrates how to set up and analyze experimen-
tal data.
Table 1 Copy Number Alteration
D1.03.01831DMD
MLPAstats Coffalyser
1357-L1005 1 1
1361-L1009 1 1
1363-L1011 -1 0
1365-L1013 1 1
1373-L1021 1 1
1385-L1033 1 1
1713-L1281 1 1
1715-L1283 1 1
1718-L1286 1 1
1897-L1008 -1 0
1954-L1574 1 1
D1.04.04280DMD
MLPAstats Coffalyser
1385-L1033 -1 -1
1715-L1283 -1 -1
1718-L1286 -1 -1
D1.05.05580DMD
MLPAstats Coffalyser
1355-L1615 1 0
1370-L1287 -1 -1
1374-L1288 -1 -1
1378-L1026 -1 -1
1382-L1030 -1 -1
1390-L1038 -1 Amb
1711-L1279 1 0
1717-L1285 -1 -1
Prediction of copy number alteration using MLPAstats and Coffalyser for the
test sample DMD P034-1, distributed with Coffalyser. Key: 1-Gain, 0-Normal,
-1-Loss, Amb-Ambiguos. Only samples with copy number alteration are
shown.
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Page 6 of 7Availability and requirements
1. Project name: MLPAstats
2. Project home page: http://www.creal.cat/jrgonzalez/
software.htm and http://www.cran.r-project.org
3. Operating system(s): Platform independent
4. Programming language: R
5. R Dependencies: nmle, boot, tcltk, tkrplot, pixmap
6. License: GPL or newer
Additional material
Additional file 1: Document that shows a step-by step manual of
MLPAstats.
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